MedPath

Effect of Panchgavya Ghrita and Sarswata Choorna in Chintajanaya Manasika Rog

Phase 2
Conditions
Health Condition 1: null- 1)Patients who are fulfilling the DSM IV TR Diagnostic criteria for generalized anxiety disorders
Registration Number
CTRI/2016/12/007521
Lead Sponsor
IPGT and RA Jamnagar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Patients who are fulfilling the DSM IV TR Diagnostic criteria for generalized anxiety disorders

Exclusion Criteria

Patients presenting with major illness and psychotic disorders

Patients below 16 years of age and above 60 years

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
It is expected that the trial drugs will exert a <br/ ><br>significant action on Signs and Symptoms of <br/ ><br>chittodweg. Improvement in Hemilton Anxienty Rating Scale, Manasa Parikshya Bhav and Quality of life of Patients.Timepoint: 2)After preliminary registration diagnostic medical history will be taken according to both Ayurveda and modern. Before and after treatment, patients state of anxiety will be assessed by Quality of life scale and Hamilton Anxiety Rating Scale. Along with this scales, various parameter will also be assessed.
Secondary Outcome Measures
NameTimeMethod
By providing better effect on General Anxiety Disorder, the drug will effect psychosomatic level of the enrolled patients, enhance quality of life and will contribute in reducing disability adjusted life years. <br/ ><br>Overall improvement in the disease condition, Quality of Life of the diseased. <br/ ><br>Based on the observations, the trial drug may be <br/ ><br>recommended to be added into the Essential Drugs List of Ministry of AYUSH, New DelhiTimepoint: 18 months
© Copyright 2025. All Rights Reserved by MedPath